<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=379649259166033&amp;ev=PageView&amp;noscript=1">


Building a Translational Medicine Institute for the Next Decade

December 2, 2021 at 9AM PT, 12PM ET and 17:00 GMT

The Indiana Biosciences Research Institute (IBRI) was established by bringing together talents and knowledge from public and private sectors to deliver important answers to metabolic diseases.

Join us in a conversation with IBRI's leadership team and learn about their approach to building a world-class translational medicine institute.

Janice-Kranz-200px Alan-Palkowitz-200px Tim-Richardson-200px Michael-Kalwat-200px
Janice Kranz, Ph.D.
CEO, Eikonizo Therapeutics
Alan Palkowitz, Ph.D.
President & CEO, IBRI
Timothy Richardson, Ph.D.
Scientific Director, IBRI
Michael Kalwat, Ph.D.
Assistant Investigator, IBRI

Speaker biography

Discussion topics will include:

  • New research areas for treatment of Alzheimer's disease, diabetes, and other metabolic diseases
  • The challenges and opportunities in translational research, and what makes IBRI different
  • The differences of working in big pharma, academia, and non-profit

Enter your email address to reserve your FREE webinar seat now. 

Can't make it to the live webinar? Register to receive link to the on-demand recording.

Reserve Your Webinar Seat: